Co-Occurring Sentences	Sentence Position in R	Fixed Term	Term1	Term2	PMID
 ER-60 is a thiol oxidoreductase family protein of the endoplasmic reticulum that facilitates the oxidative folding of glycoproteins via interaction with calnexin (CNX) and calreticulin (CRT).	2	facilitate|interacts facilitate|interaction	ER-60	CNX	15236594
			ER-60	CNX	15236594
 ER-60 is a thiol oxidoreductase family protein of the endoplasmic reticulum that facilitates the oxidative folding of glycoproteins via interaction with calnexin (CNX) and calreticulin (CRT).	2	facilitate|interacts facilitate|interaction	ER-60	CRT	15236594
			ER-60	CRT	15236594
			CNX	CRT	15236594
			CNX	CRT	15236594
			CNX	CRT	15236594
			Cox-2	EGFR	15246187
" Epidermal growth factor receptor (EGFR) signaling regulates Cox-2 expression, which has not been thoroughly examined in bronchial carcinomas."	3	regulates	Cox-2	EGFR	15246187
			Cox-2	EGFR	15246187
 Higher Cox-2 expression (more than 10% immunoreactivities in tumor cells) was strongly associated with higher EGFR and P53 expression as well as a Ki-67 LI above 20% (P &lt; 0.01).	6	immunoassociate|reactivities associate|reactd	Cox-2	EGFR	15246187
			Cox-2	EGFR	15246187
 Higher Cox-2 expression might be associated with tumor progression and worse prognosis through EGFR signaling interaction in Stage I bronchial adenocarcinomas.	9	associate|interactd	Cox-2	EGFR	15246187
			Cox-2	P53	15246187
 Higher Cox-2 expression (more than 10% immunoreactivities in tumor cells) was strongly associated with higher EGFR and P53 expression as well as a Ki-67 LI above 20% (P &lt; 0.01).	6	immunoassociate|reactivities associate|reactd	Cox-2	P53	15246187
			Cox-2	Ki-67	15246187
 Higher Cox-2 expression (more than 10% immunoreactivities in tumor cells) was strongly associated with higher EGFR and P53 expression as well as a Ki-67 LI above 20% (P &lt; 0.01).	6	immunoassociate|reactivities associate|reactd	Cox-2	Ki-67	15246187
			EGFR	P53	15246187
			EGFR	P53	15246187
			EGFR	Ki-67	15246187
			EGFR	Ki-67	15246187
			P53	Ki-67	15246187
			P53	Ki-67	15246187
			AQP1	AQP3	15248066
			AQP1	AQP3	15248066
			AQP1	AQP4	15248066
			AQP1	AQP4	15248066
			AQP1	AQP4	15248066
			AQP1	AQP5	15248066
			AQP1	AQP5	15248066
			AQP1	AQP5	15248066
			AQP1	ENaC	15248066
			AQP1	CFTR	15248066
			AQP3	AQP4	15248066
			AQP3	AQP4	15248066
			AQP3	AQP5	15248066
			AQP3	AQP5	15248066
			AQP3	ENaC	15248066
			AQP3	CFTR	15248066
			AQP4	AQP5	15248066
			AQP4	AQP5	15248066
			AQP4	AQP5	15248066
			AQP4	ENaC	15248066
			AQP4	CFTR	15248066
			AQP5	ENaC	15248066
			AQP5	CFTR	15248066
			ENaC	CFTR	15248066
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced	rsCD154	TNFalpha	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	rsCD154	TNFalpha	15248214
			rsCD154	TNFalpha	15248214
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced	rsCD154	IL-1alpha	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	rsCD154	IL-1alpha	15248214
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced	rsCD154	IL-1beta	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	rsCD154	IL-1beta	15248214
			rsCD154	IL-1beta	15248214
			rsCD154	IFNgamma	15248214
			rsCD154	IFNgamma	15248214
			rsCD154	IFNgamma	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	rsCD154	IL-6	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	rsCD154	IL-8	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	rsCD154	monocyte chemoattractant protein 1	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	rsCD154	ERK-1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	rsCD154	ERK-1	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	rsCD154	ERK-2	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	rsCD154	ERK-2	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	rsCD154	p38 MAPK	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	rsCD154	p38 MAPK	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	rsCD154	NF-kappaB	15248214
			rsCD154	CD40	15248214
			rsCD154	CD154	15248214
			TNFalpha	IL-1alpha	15248214
			TNFalpha	IL-1alpha	15248214
			TNFalpha	IL-1alpha	15248214
			TNFalpha	IL-1beta	15248214
			TNFalpha	IL-1beta	15248214
			TNFalpha	IL-1beta	15248214
			TNFalpha	IL-1beta	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	TNFalpha	IFNgamma	15248214
			TNFalpha	IFNgamma	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	TNFalpha	IL-6	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	TNFalpha	IL-8	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	TNFalpha	monocyte chemoattractant protein 1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	TNFalpha	ERK-1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	TNFalpha	ERK-2	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	TNFalpha	p38 MAPK	15248214
			TNFalpha	NF-kappaB	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	TNFalpha	CD40	15248214
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced induced	TNFalpha	CD154	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	TNFalpha	CD154	15248214
			IL-1alpha	IL-1beta	15248214
			IL-1alpha	IL-1beta	15248214
			IL-1alpha	IL-1beta	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	IL-1alpha	IFNgamma	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1alpha	IL-6	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1alpha	IL-8	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1alpha	monocyte chemoattractant protein 1	15248214
			IL-1alpha	ERK-1	15248214
			IL-1alpha	ERK-2	15248214
			IL-1alpha	p38 MAPK	15248214
			IL-1alpha	NF-kappaB	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	IL-1alpha	CD40	15248214
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced induced	IL-1alpha	CD154	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	IL-1alpha	CD154	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated uninduce|stimulated	IL-1beta	IFNgamma	15248214
			IL-1beta	IFNgamma	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1beta	IL-6	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1beta	IL-8	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	uninduce|stimulated	IL-1beta	monocyte chemoattractant protein 1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IL-1beta	ERK-1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IL-1beta	ERK-2	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IL-1beta	p38 MAPK	15248214
			IL-1beta	NF-kappaB	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	IL-1beta	CD40	15248214
" Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta."	9	induced induced	IL-1beta	CD154	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	IL-1beta	CD154	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	IFNgamma	IL-6	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	IFNgamma	IL-8	15248214
" CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."	10	induce|stimulated	IFNgamma	monocyte chemoattractant protein 1	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	IFNgamma	ERK-1	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IFNgamma	ERK-1	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	IFNgamma	ERK-2	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IFNgamma	ERK-2	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	IFNgamma	p38 MAPK	15248214
" Specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients."	12	inhibit|reduce|stimulated	IFNgamma	p38 MAPK	15248214
" Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB."	11	induced	IFNgamma	NF-kappaB	15248214
			IFNgamma	CD40	15248214
			IFNgamma	CD154	15248214
			IL-6	IL-8	15248214
			IL-6	monocyte chemoattractant protein 1	15248214
			IL-6	ERK-1	15248214
			IL-6	ERK-2	15248214
			IL-6	p38 MAPK	15248214
			IL-6	NF-kappaB	15248214
			IL-6	CD40	15248214
			IL-6	CD154	15248214
			IL-8	monocyte chemoattractant protein 1	15248214
			IL-8	ERK-1	15248214
			IL-8	ERK-2	15248214
			IL-8	p38 MAPK	15248214
			IL-8	NF-kappaB	15248214
			IL-8	CD40	15248214
			IL-8	CD154	15248214
			monocyte chemoattractant protein 1	ERK-1	15248214
			monocyte chemoattractant protein 1	ERK-2	15248214
			monocyte chemoattractant protein 1	p38 MAPK	15248214
			monocyte chemoattractant protein 1	NF-kappaB	15248214
			monocyte chemoattractant protein 1	CD40	15248214
			monocyte chemoattractant protein 1	CD154	15248214
			ERK-1	ERK-2	15248214
			ERK-1	ERK-2	15248214
			ERK-1	p38 MAPK	15248214
			ERK-1	p38 MAPK	15248214
			ERK-1	NF-kappaB	15248214
			ERK-1	CD40	15248214
			ERK-1	CD154	15248214
			ERK-2	p38 MAPK	15248214
			ERK-2	p38 MAPK	15248214
			ERK-2	NF-kappaB	15248214
			ERK-2	CD40	15248214
			ERK-2	CD154	15248214
			p38 MAPK	NF-kappaB	15248214
			p38 MAPK	CD40	15248214
			p38 MAPK	CD154	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	NF-kappaB	CD40	15248214
" These data indicate that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS."	13	activate|interaction activate|interacts	NF-kappaB	CD154	15248214
			CD40	CD154	15248214
			CD40	CD154	15248214
			HO-1	AT1	15251861
			HO-1	PKC	15251861
			HO-1	HO-2	15251861
			AT1	PKC	15251861
			AT1	HO-2	15251861
			PKC	HO-2	15251861
			Hsp90	Cdc37	15258137
			Hsp90	Cdc37	15258137
			Hsp90	Cdc37	15258137
" Two parameters were assayed: the ability and extent to which the constructs bound to Hsp90 and Cdc37, and the ability of the constructs to trigger salt-resistant high affinity complexes with Hsp90 and Cdc37 independent of the presence of molybdate."	4	complex|trigger complex|trigger complex|triggeres complex|triggeres	Hsp90	Cdc37	15258137
			Hsp90	Cdc37	15258137
			Hsp90	Cdc37	15258137
" In this report, the crystal structure of the Src family tyrosine kinase Lck was used to guide the creation of kinase constructs to determine features recognized by Hsp90 and its \kinase-specific\ co-chaperone Cdc37."	3	determine	Hsp90	Lck	15258137
" In this report, the crystal structure of the Src family tyrosine kinase Lck was used to guide the creation of kinase constructs to determine features recognized by Hsp90 and its \kinase-specific\ co-chaperone Cdc37."	3	determine	Cdc37	Lck	15258137
 Cdc37 interacted with only the NL and minimally required the alpha-C-helix and beta4- and beta5-strands of this lobe of Lck.	8	interacted	Cdc37	Lck	15258137
			PLTP	HDL	15258196
			PLTP	HDL	15258196
			PLTP	HDL	15258196
			PLTP	HDL	15258196
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.	1	induce|reduces	PLTP	LDL	15258196
" Because the decreased atherosclerosis was accompanied by a significant decrease in plasma HDL levels, we examined the properties of PLTP knockout (PLTP0) HDL and tested its ability to prevent LDL-induced monocyte chemotactic activity in human artery wall cell cocultures."	3	decrease|induce|prevent decrease|induce|prevent	PLTP	LDL	15258196
			PLTP	LDL	15258196
 We conclude that PLTP deficiency improves the anti-inflammatory properties of HDL in mice and reduces the ability of LDL to induce monocyte chemotactic activity.	10	induce|reduces	PLTP	LDL	15258196
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.	1	induce|reduces	HDL	LDL	15258196
" Because the decreased atherosclerosis was accompanied by a significant decrease in plasma HDL levels, we examined the properties of PLTP knockout (PLTP0) HDL and tested its ability to prevent LDL-induced monocyte chemotactic activity in human artery wall cell cocultures."	3	decrease|induce|prevent decrease|induce|prevent	HDL	LDL	15258196
			HDL	LDL	15258196
 The ability of HDL from LDLr0/PLTP0 and apoBTg/PLTP0 mice to prevent the induction of monocyte chemotactic activity in human artery wall cell cocultures exposed to human LDL was dramatically better than that in controls.	7	prevent	HDL	LDL	15258196
			HDL	LDL	15258196
 We conclude that PLTP deficiency improves the anti-inflammatory properties of HDL in mice and reduces the ability of LDL to induce monocyte chemotactic activity.	10	induce|reduces	HDL	LDL	15258196
			Cyclin D1	Cyclin E	15263796
			Cyclin D1	p21	15263796
			Cyclin D1	p27	15263796
			Cyclin D1	pRb	15263796
			Cyclin D1	p53	15263796
			Cyclin D1	Ki-67	15263796
			Cyclin D1	PCNA	15263796
			Cyclin E	p21	15263796
			Cyclin E	p27	15263796
			Cyclin E	pRb	15263796
			Cyclin E	p53	15263796
			Cyclin E	Ki-67	15263796
			Cyclin E	PCNA	15263796
			p21	p27	15263796
			p21	p27	15263796
			p21	p27	15263796
			p21	p27	15263796
			p21	p27	15263796
			p21	pRb	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p21	p53	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p21	Ki-67	15263796
			p21	Ki-67	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p21	PCNA	15263796
			p27	pRb	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p27	p53	15263796
			p27	p53	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p27	Ki-67	15263796
			p27	Ki-67	15263796
			p27	Ki-67	15263796
"Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features."	1	cell-cycle-inhibit|related	p27	PCNA	15263796
			p27	PCNA	15263796
			pRb	p53	15263796
" The expression of these proteins was also analyzed along with other cell-cycle-related proteins such as: p53, pRb and the proliferation-associated indices Ki-67 and proliferating cell nuclear antigen (PCNA)."	3	proliferation-associate|related	pRb	Ki-67	15263796
" The expression of these proteins was also analyzed along with other cell-cycle-related proteins such as: p53, pRb and the proliferation-associated indices Ki-67 and proliferating cell nuclear antigen (PCNA)."	3	proliferation-associate|related	pRb	PCNA	15263796
			p53	Ki-67	15263796
" The expression of these proteins was also analyzed along with other cell-cycle-related proteins such as: p53, pRb and the proliferation-associated indices Ki-67 and proliferating cell nuclear antigen (PCNA)."	3	proliferation-associate|related	p53	Ki-67	15263796
			p53	Ki-67	15263796
			p53	PCNA	15263796
" The expression of these proteins was also analyzed along with other cell-cycle-related proteins such as: p53, pRb and the proliferation-associated indices Ki-67 and proliferating cell nuclear antigen (PCNA)."	3	proliferation-associate|related	p53	PCNA	15263796
			p53	PCNA	15263796
			Ki-67	PCNA	15263796
			Ki-67	PCNA	15263796
			Ki-67	PCNA	15263796
			PDGF	Sp1	15297375
 Overexpression of Ets-1 but not the mutant form of Ets-1 activates the PDGF promoter cooperatively with Sp1.	9	activate|promoter	PDGF	Sp1	15297375
" Sp1, which interacts with Ets-1, failed to induce PDGF promoter-dependent expression if the promoter contained a site-specific mutation in this novel Ets-binding site."	10	bind|induce|interact|promotes bind|induce|interact|promote	PDGF	Sp1	15297375
 Small interfering RNA to Ets-1 and Sp1 blocked PDGF and serum-inducible PDGF expression.	11	blocked blocked	PDGF	Sp1	15297375
 These findings identify a functional cis-acting element for Ets-1 in the PDGF promoter and demonstrate that Sp1 and Ets-1 cooperatively activate PDGF transcription in vascular SMCs.	14	activate|promoter activate|promote	PDGF	Sp1	15297375
			PDGF	Sp3	15297375
			PDGF	Egr-1	15297375
			PDGF	GCF2	15297375
			PDGF	NF-1	15297375
			PDGF	WT-1	15297375
" In this article, we demonstrate that Ets-1 induces PDGF expression in primary rat aortic SMCs at the level of transcription and mRNA expression."	5	induces	PDGF	Ets-1	15297375
" Electrophoretic mobility shift, supershift, and mutational analyses revealed a functional role for the (-555)TTCC(-552) motif in the PDGF promoter that binds endogenous Ets-1."	6	bind|promoter bind|promotes	PDGF	Ets-1	15297375
" Chromatin immunoprecipitation analysis showed the interaction of endogenous and exogenous Ets-1 or glutathione S-transferase-tagged Ets-1, bearing only the DNA-binding domain with the authentic PDGF promoter."	7	DNA-bind|interact|promoteing DNA-bind|interact|promoteing	PDGF	Ets-1	15297375
 Overexpression of Ets-1 but not the mutant form of Ets-1 activates the PDGF promoter cooperatively with Sp1.	9	activate|promotes activate|promotes	PDGF	Ets-1	15297375
" Sp1, which interacts with Ets-1, failed to induce PDGF promoter-dependent expression if the promoter contained a site-specific mutation in this novel Ets-binding site."	10	bind|induce|interact|promote	PDGF	Ets-1	15297375
 Small interfering RNA to Ets-1 and Sp1 blocked PDGF and serum-inducible PDGF expression.	11	blocked blocked	PDGF	Ets-1	15297375
" Ets-1-inducible mitogenesis is blocked by antibodies neutralizing PDGF and involves activation of the PDGF alpha-receptor, which binds PDGF."	13	bind|blocked bind|blocked bind|blocked bind|blocks	PDGF	Ets-1	15297375
 These findings identify a functional cis-acting element for Ets-1 in the PDGF promoter and demonstrate that Sp1 and Ets-1 cooperatively activate PDGF transcription in vascular SMCs.	14	activate|promoter activate|promoter activate|promote activate|promote	PDGF	Ets-1	15297375
			Sp1	Sp3	15297375
			Sp1	Egr-1	15297375
			Sp1	GCF2	15297375
			Sp1	NF-1	15297375
			Sp1	WT-1	15297375
Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1.	1	chain|interact|stimulates A-chain|interact|stimulate chain|interact|stimulateions	Sp1	Ets-1	15297375
 Overexpression of Ets-1 but not the mutant form of Ets-1 activates the PDGF promoter cooperatively with Sp1.	9	activate|promotes activate|promotes activate|promoter activate|promoter	Sp1	Ets-1	15297375
" Sp1, which interacts with Ets-1, failed to induce PDGF promoter-dependent expression if the promoter contained a site-specific mutation in this novel Ets-binding site."	10	bind|induce|interact|promotes	Sp1	Ets-1	15297375
			Sp1	Ets-1	15297375
			Sp1	Ets-1	15297375
 These findings identify a functional cis-acting element for Ets-1 in the PDGF promoter and demonstrate that Sp1 and Ets-1 cooperatively activate PDGF transcription in vascular SMCs.	14	activate|promoter	Sp1	Ets-1	15297375
			Sp3	Egr-1	15297375
			Sp3	GCF2	15297375
			Sp3	NF-1	15297375
			Sp3	WT-1	15297375
			Sp3	Ets-1	15297375
			Egr-1	GCF2	15297375
			Egr-1	NF-1	15297375
			Egr-1	WT-1	15297375
			Egr-1	Ets-1	15297375
			GCF2	NF-1	15297375
			GCF2	WT-1	15297375
			GCF2	Ets-1	15297375
			NF-1	WT-1	15297375
			NF-1	Ets-1	15297375
			WT-1	Ets-1	15297375
CD46 mediated costimulation induces a Th1 biased response and enhances early TCR CD3 signaling in human CD4+ T lymphocytes.	1	enhance|induces enhance|induces	CD46	CD3	15307176
			CD46	CD3	15307176
			CD46	CD3	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced enhance|induced	CD46	CD3	15307176
" However, CD46 cross-linking by itself did not induce cell proliferation or lymphokine secretion, and pretreatment of CD4+ T lymphocytes with anti-CD46 antibodies did not significantly alter TCR CD3 activation."	11	cross-induce|linking induce|link	CD46	CD3	15307176
			CD46	CD28	15307176
			CD46	CD28	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD46	IL-2	15307176
 CD46 also enhanced IL-2 or IFN-gamma secretion by CD4+ blasts.	5	enhanced	CD46	IL-2	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD46	IFN-gamma	15307176
 CD46 also enhanced IL-2 or IFN-gamma secretion by CD4+ blasts.	5	enhanced	CD46	IFN-gamma	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD46	IL-10	15307176
			CD46	IL-10	15307176
			CD46	IL-12	15307176
" In contrast, IL-5 secretion was inhibited upon CD46 CD3 coligation, in all the cells analyzed."	6	inhibited	CD46	IL-5	15307176
CD46 mediated costimulation induces a Th1 biased response and enhances early TCR CD3 signaling in human CD4+ T lymphocytes.	1	enhance|induces enhance|induces	CD46	TCR	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD46	TCR	15307176
" However, CD46 cross-linking by itself did not induce cell proliferation or lymphokine secretion, and pretreatment of CD4+ T lymphocytes with anti-CD46 antibodies did not significantly alter TCR CD3 activation."	11	cross-induce|linking induce|link	CD46	TCR	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced	CD46	CD3zeta	15307176
 Cross-linking CD46 alone induced weak tyrosine phosphorylation of CD3zeta and ZAP-70.	10	induce|linkd	CD46	CD3zeta	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced	CD46	ZAP-70	15307176
 Cross-linking CD46 alone induced weak tyrosine phosphorylation of CD3zeta and ZAP-70.	10	induce|linkd	CD46	ZAP-70	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced	CD46	ERK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced	CD46	JNK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced enhance|induced	CD46	p38	15307176
			CD3	CD28	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD3	IL-2	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD3	IFN-gamma	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD3	IL-10	15307176
			CD3	IL-12	15307176
" In contrast, IL-5 secretion was inhibited upon CD46 CD3 coligation, in all the cells analyzed."	6	inhibited	CD3	IL-5	15307176
			CD3	TCR	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	TCR	15307176
			CD3	TCR	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	CD3zeta	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	ZAP-70	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	ERK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	JNK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	CD3	p38	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD28	IL-2	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD28	IFN-gamma	15307176
" Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."	3	enhanced	CD28	IL-10	15307176
			CD28	IL-10	15307176
			CD28	IL-12	15307176
			CD28	IL-5	15307176
			CD28	TCR	15307176
			CD28	CD3zeta	15307176
			CD28	ZAP-70	15307176
			CD28	ERK	15307176
			CD28	JNK	15307176
			CD28	p38	15307176
			IL-2	IFN-gamma	15307176
			IL-2	IFN-gamma	15307176
			IL-2	IL-10	15307176
			IL-2	IL-12	15307176
			IL-2	IL-5	15307176
			IL-2	TCR	15307176
			IL-2	CD3zeta	15307176
			IL-2	ZAP-70	15307176
			IL-2	ERK	15307176
			IL-2	JNK	15307176
			IL-2	p38	15307176
			IFN-gamma	IL-10	15307176
			IFN-gamma	IL-12	15307176
			IFN-gamma	IL-5	15307176
			IFN-gamma	TCR	15307176
			IFN-gamma	CD3zeta	15307176
			IFN-gamma	ZAP-70	15307176
			IFN-gamma	ERK	15307176
			IFN-gamma	JNK	15307176
			IFN-gamma	p38	15307176
			IL-10	IL-12	15307176
			IL-10	IL-5	15307176
			IL-10	TCR	15307176
			IL-10	CD3zeta	15307176
			IL-10	ZAP-70	15307176
			IL-10	ERK	15307176
			IL-10	JNK	15307176
			IL-10	p38	15307176
			IL-12	IL-5	15307176
			IL-12	TCR	15307176
			IL-12	CD3zeta	15307176
			IL-12	ZAP-70	15307176
			IL-12	ERK	15307176
			IL-12	JNK	15307176
			IL-12	p38	15307176
			IL-5	TCR	15307176
			IL-5	CD3zeta	15307176
			IL-5	ZAP-70	15307176
			IL-5	ERK	15307176
			IL-5	JNK	15307176
			IL-5	p38	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	TCR	CD3zeta	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	TCR	ZAP-70	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	TCR	ERK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	TCR	JNK	15307176
" CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, as well as the activation of the ERK, JNK, and p38, but did not modify intracellular calcium."	8	enhance|induced	TCR	p38	15307176
			CD3zeta	ZAP-70	15307176
			CD3zeta	ZAP-70	15307176
			CD3zeta	ERK	15307176
			CD3zeta	JNK	15307176
			CD3zeta	p38	15307176
			ZAP-70	ERK	15307176
			ZAP-70	JNK	15307176
			ZAP-70	p38	15307176
			ERK	JNK	15307176
			ERK	p38	15307176
			JNK	p38	15307176
			PDGF	IL-10	15309723
			PDGF	IL-10	15309723
			PDGF	IL-10	15309723
			PDGF	IL-10	15309723
			PDGF	Fas	15309723
			PDGF	FasL	15309723
			PDGF	Bcl-2	15309723
			PDGF	Bcl-2	15309723
			PDGF	Bax	15309723
" Contrast to the control group, after treated with PDGF and IL-10, either alone or in combination, Bcl-2 mRNA expression was down-regulated and Bax mRNA expression was up-regulated, both following the turn from group P, group I to group C."	9	down-regulated	PDGF	Bax	15309723
			IL-10	Fas	15309723
" IL-10 may promote the apoptosis of HSCs by up-regulating the expressions of FasL and Bax and down-regulating the expression of Bcl-2, which may be involved in its antifibrosis mechanism."	16	promote	IL-10	FasL	15309723
			IL-10	Bcl-2	15309723
			IL-10	Bcl-2	15309723
" IL-10 may promote the apoptosis of HSCs by up-regulating the expressions of FasL and Bax and down-regulating the expression of Bcl-2, which may be involved in its antifibrosis mechanism."	16	promote	IL-10	Bcl-2	15309723
			IL-10	Bax	15309723
" Contrast to the control group, after treated with PDGF and IL-10, either alone or in combination, Bcl-2 mRNA expression was down-regulated and Bax mRNA expression was up-regulated, both following the turn from group P, group I to group C."	9	down-regulated	IL-10	Bax	15309723
" IL-10 may promote the apoptosis of HSCs by up-regulating the expressions of FasL and Bax and down-regulating the expression of Bcl-2, which may be involved in its antifibrosis mechanism."	16	promote	IL-10	Bax	15309723
			Fas	FasL	15309723
			Fas	Bcl-2	15309723
			Fas	Bcl-2	15309723
			Fas	Bcl-2	15309723
			Fas	Bax	15309723
			Fas	Bax	15309723
			Fas	Bax	15309723
			FasL	Bcl-2	15309723
			FasL	Bcl-2	15309723
			FasL	Bax	15309723
			FasL	Bax	15309723
			Bcl-2	Bax	15309723
			Bcl-2	Bax	15309723
			Bcl-2	Bax	15309723
" Contrast to the control group, after treated with PDGF and IL-10, either alone or in combination, Bcl-2 mRNA expression was down-regulated and Bax mRNA expression was up-regulated, both following the turn from group P, group I to group C."	9	down-regulated	Bcl-2	Bax	15309723
			Bcl-2	Bax	15309723
			GILZ	Bcl-xL	15319285
			GILZ	Bcl-xL	15319285
" Moreover, GILZ delivered inside WT thymocytes by a fusion protein with the transactivator of transcription (TAT) peptide decreased Bcl-xL and promoted their apoptosis."	8	decrease|promoted	GILZ	Bcl-xL	15319285
 Time-course experiments showed that in wild-type (WT) thymocytes GILZ up-regulation was followed by sequential Bcl-xL decreased expression and activation of caspase-8 and of caspase-3.	7	decreased	GILZ	caspase-8	15319285
 Time-course experiments showed that in wild-type (WT) thymocytes GILZ up-regulation was followed by sequential Bcl-xL decreased expression and activation of caspase-8 and of caspase-3.	7	decreased	GILZ	caspase-3	15319285
			GILZ	TAT	15319285
 Apoptotic pathway analysis detected reduced antiapoptotic B-cell leukemia XL (Bcl-xL) expression and increased activation of caspase-8 and caspase-3.	6	increase|reduced	Bcl-xL	caspase-8	15319285
 Time-course experiments showed that in wild-type (WT) thymocytes GILZ up-regulation was followed by sequential Bcl-xL decreased expression and activation of caspase-8 and of caspase-3.	7	decreased	Bcl-xL	caspase-8	15319285
 Apoptotic pathway analysis detected reduced antiapoptotic B-cell leukemia XL (Bcl-xL) expression and increased activation of caspase-8 and caspase-3.	6	increase|reduced	Bcl-xL	caspase-3	15319285
 Time-course experiments showed that in wild-type (WT) thymocytes GILZ up-regulation was followed by sequential Bcl-xL decreased expression and activation of caspase-8 and of caspase-3.	7	decreased	Bcl-xL	caspase-3	15319285
" Moreover, GILZ delivered inside WT thymocytes by a fusion protein with the transactivator of transcription (TAT) peptide decreased Bcl-xL and promoted their apoptosis."	8	decrease|promoted	Bcl-xL	TAT	15319285
			caspase-8	caspase-3	15319285
			caspase-8	caspase-3	15319285
			caspase-8	TAT	15319285
			caspase-3	TAT	15319285
" We therefore investigated whether nicotine could promote tumor growth and neovascularization in vivo, and the biological mechanism(s) in connection with the signaling cascade involving COX-2 and extracellular signal-regulated protein kinase (ERK)."	5	signal-connect|promote|regulated	COX-2	ERK	15319299
			COX-2	ERK	15319299
" Consistent with our animal model, an in vitro study also demonstrated that incubation with nicotine (50-200 microg/ml) for 5 h stimulated cell proliferation dose-dependently and increased COX-2 expression, prostaglandin E(2) (PGE(2)) and VEGF release, as well as activation of ERK phosphorylation."	9	"increase|release|stimulate,"	COX-2	ERK	15319299
			COX-2	ERK	15319299
			COX-2	PCNA	15319299
			COX-2	VEGF	15319299
			COX-2	VEGF	15319299
" Furthermore, the stimulatory action of nicotine on cancer cell growth and angiogenic factor VEGF production was suppressed by inhibitors of MEK (U0126) and COX-2 (SC-236)."	11	inhibit|suppressed inhibit|suppressors	COX-2	VEGF	15319299
			COX-2	VEGF	15319299
			COX-2	PGE(2)	15319299
			ERK	PCNA	15319299
			ERK	VEGF	15319299
" Consistent with our animal model, an in vitro study also demonstrated that incubation with nicotine (50-200 microg/ml) for 5 h stimulated cell proliferation dose-dependently and increased COX-2 expression, prostaglandin E(2) (PGE(2)) and VEGF release, as well as activation of ERK phosphorylation."	9	"increase|release|stimulate,"	ERK	VEGF	15319299
			ERK	VEGF	15319299
			ERK	PGE(2)	15319299
			PCNA	VEGF	15319299
			PCNA	PGE(2)	15319299
			VEGF	PGE(2)	15319299
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silenced complex|decrease|silence	XBP-1	HMGB1	22504285
" Moreover, XBP-1 silenced DCs after treatment with HMGB1 failed to stimulate notable proliferation and differentiation of T cells, unlike normal DCs or nontargeting-transfected DCs (all P&lt;0.05)."	6	silence|stimulated	XBP-1	HMGB1	22504285
 Gene silence of XBP-1 resulted in down-regulation of the receptor for advanced glycation end products (RAGE) expression on the surface of splenic DCs induced by HMGB1 stimulation (P&lt;0.05).	7	induce|silenced	XBP-1	HMGB1	22504285
			XBP-1	HMGB1	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silenced	XBP-1	CD80	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silenced	XBP-1	CD86	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silenced complex|decrease|silence	XBP-1	MHC-II	22504285
			XBP-1	RAGE	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silence	HMGB1	CD80	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silence	HMGB1	CD86	22504285
			HMGB1	MHC-II	22504285
 Gene silence of XBP-1 resulted in down-regulation of the receptor for advanced glycation end products (RAGE) expression on the surface of splenic DCs induced by HMGB1 stimulation (P&lt;0.05).	7	induce|silenced	HMGB1	RAGE	22504285
			CD80	CD86	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silence	CD80	MHC-II	22504285
			CD80	RAGE	22504285
" Gene silence of XBP-1 in splenic DCs decreased the levels of CD80, CD86 as well as major histocompatibility complex MHC-II expression and cytokine secretion after HMGB1 treatment, when compared with untransfected or nontargeting-transfected DCs (all P&lt;0.05)."	5	complex|decrease|silence	CD86	MHC-II	22504285
			CD86	RAGE	22504285
			MHC-II	RAGE	22504285
"GDF-9 and bFGF enhance the effect of FSH on the survival, activation, and growth of cattle primordial follicles."	1	enhance	FSH	GDF-9	22516229
			FSH	GDF-9	22516229
			FSH	GDF-9	22516229
			FSH	GDF-9	22516229
			FSH	GDF-9	22516229
			FSH	GDF-9	22516229
"GDF-9 and bFGF enhance the effect of FSH on the survival, activation, and growth of cattle primordial follicles."	1	enhance	FSH	bFGF	22516229
			FSH	bFGF	22516229
			FSH	bFGF	22516229
 FSH+bFGF medium appeared to increase the percentage of primary follicles after 14 days of culture and secondary follicles at day 14 of culture than FSH medium (P&lt;0.05).	6	increase	FSH	bFGF	22516229
			FSH	bFGF	22516229
			FSH	bFGF	22516229
			GDF-9	bFGF	22516229
			GDF-9	bFGF	22516229
			GDF-9	bFGF	22516229
			GDF-9	bFGF	22516229
			GDF-9	bFGF	22516229
Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.	1	associate|impair|paird	TLR9	S100A8	26525587
 TLR9 activation induces release of pro-inflammatory molecules like S100A8 and interleukin-8 (IL-8) by myeloid cells causing migration of myeloid cells to the site of inflammation.	5	induce|releases induce|release	TLR9	S100A8	26525587
			TLR9	S100A8	26525587
" TLR9 down-stream effector molecules S100A8 and IL-8 were also increased in diabetic wounds (p=0.003, t=3.1 for S100A8 mRNA; p=0.04, t=2.04 for IL-8)."	10	increased	TLR9	S100A8	26525587
Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.	1	associate|impair|paird	TLR9	IL-8	26525587
 TLR9 activation induces release of pro-inflammatory molecules like S100A8 and interleukin-8 (IL-8) by myeloid cells causing migration of myeloid cells to the site of inflammation.	5	induce|releases induce|release	TLR9	IL-8	26525587
			TLR9	IL-8	26525587
" TLR9 down-stream effector molecules S100A8 and IL-8 were also increased in diabetic wounds (p=0.003, t=3.1 for S100A8 mRNA; p=0.04, t=2.04 for IL-8)."	10	increased	TLR9	IL-8	26525587
			S100A8	IL-8	26525587
			S100A8	IL-8	26525587
			S100A8	IL-8	26525587
			S100A8	IL-8	26525587
" TLR9 down-stream effector molecules S100A8 and IL-8 were also increased in diabetic wounds (p=0.003, t=3.1 for S100A8 mRNA; p=0.04, t=2.04 for IL-8)."	10	increased increased	S100A8	IL-8	26525587
			S100A8	IL-8	26525587
			FXR	NR0B2	26812075
			FXR	ABCB11	26812075
			FXR	SLC51A	26812075
			FXR	SLC51B	26812075
			FXR	ABCB4	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	AKAP13	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	CGNL1	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	DYRK3	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	PDIA5	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	PPP1R3B	26812075
" ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."	11	binding	FXR	TBX6	26812075
			NR0B2	ABCB11	26812075
			NR0B2	SLC51A	26812075
			NR0B2	SLC51B	26812075
			NR0B2	ABCB4	26812075
			NR0B2	AKAP13	26812075
			NR0B2	CGNL1	26812075
			NR0B2	DYRK3	26812075
			NR0B2	PDIA5	26812075
			NR0B2	PPP1R3B	26812075
			NR0B2	TBX6	26812075
			ABCB11	SLC51A	26812075
			ABCB11	SLC51B	26812075
			ABCB11	ABCB4	26812075
			ABCB11	AKAP13	26812075
			ABCB11	CGNL1	26812075
			ABCB11	DYRK3	26812075
			ABCB11	PDIA5	26812075
			ABCB11	PPP1R3B	26812075
			ABCB11	TBX6	26812075
			SLC51A	SLC51B	26812075
			SLC51A	ABCB4	26812075
			SLC51A	AKAP13	26812075
			SLC51A	CGNL1	26812075
			SLC51A	DYRK3	26812075
			SLC51A	PDIA5	26812075
			SLC51A	PPP1R3B	26812075
			SLC51A	TBX6	26812075
			SLC51B	ABCB4	26812075
			SLC51B	AKAP13	26812075
			SLC51B	CGNL1	26812075
			SLC51B	DYRK3	26812075
			SLC51B	PDIA5	26812075
			SLC51B	PPP1R3B	26812075
			SLC51B	TBX6	26812075
			ABCB4	AKAP13	26812075
			ABCB4	CGNL1	26812075
			ABCB4	DYRK3	26812075
			ABCB4	PDIA5	26812075
			ABCB4	PPP1R3B	26812075
			ABCB4	TBX6	26812075
			AKAP13	CGNL1	26812075
			AKAP13	DYRK3	26812075
			AKAP13	PDIA5	26812075
			AKAP13	PPP1R3B	26812075
			AKAP13	TBX6	26812075
			CGNL1	DYRK3	26812075
			CGNL1	PDIA5	26812075
			CGNL1	PPP1R3B	26812075
			CGNL1	TBX6	26812075
			DYRK3	PDIA5	26812075
			DYRK3	PPP1R3B	26812075
			DYRK3	TBX6	26812075
			PDIA5	PPP1R3B	26812075
			PDIA5	TBX6	26812075
			PPP1R3B	TBX6	26812075
			Akh	AHR	27100621
			Akh	NR1I2	27100621
			Akh	ABCB1	27100621
			Akh	ABCC3	27100621
			Akh	CYP3A4	27100621
			AHR	NR1I2	27100621
			AHR	ABCB1	27100621
			AHR	ABCC3	27100621
			AHR	CYP3A4	27100621
			NR1I2	ABCB1	27100621
			NR1I2	ABCC3	27100621
			NR1I2	CYP3A4	27100621
			ABCB1	ABCC3	27100621
			ABCB1	CYP3A4	27100621
			ABCC3	CYP3A4	27100621
			TCF7L2	HHEX	27551309
			TCF7L2	HNF1A	27551309
			TCF7L2	NOTCH2	27551309
			TCF7L2	NOTCH2	27551309
			TCF7L2	TLE4	27551309
			TCF7L2	PPARG	27551309
			TCF7L2	ZBED3	27551309
			TCF7L2	ZBED3	27551309
			HHEX	HNF1A	27551309
			HHEX	NOTCH2	27551309
			HHEX	TLE4	27551309
			HHEX	PPARG	27551309
			HHEX	ZBED3	27551309
			HNF1A	NOTCH2	27551309
			HNF1A	TLE4	27551309
			HNF1A	PPARG	27551309
			HNF1A	ZBED3	27551309
			NOTCH2	TLE4	27551309
			NOTCH2	PPARG	27551309
			NOTCH2	ZBED3	27551309
			NOTCH2	ZBED3	27551309
			NOTCH2	ZBED3	27551309
			TLE4	PPARG	27551309
			TLE4	ZBED3	27551309
			PPARG	ZBED3	27551309
			IL-6	IL-10	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-6	MCP-1	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-6	CXCL10	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-6	IL-8	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-10	MCP-1	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-10	CXCL10	30445175
" Additionally, an immunomodulatory effect of the probiotics was seen; production of anti-inflammatory cytokines (IL-6 and IL-10) was increased and production of inflammatory chemokines (MCP-1, CXCL10 and IL-8.) was reduced."	7	increase|reduced	IL-10	IL-8	30445175
			MCP-1	CXCL10	30445175
			MCP-1	IL-8	30445175
			CXCL10	IL-8	30445175
" In the previous studies, we have shown that FLCN could inhibit the binding of overexpressed PAT1, which is a membrane-bound amino acid transporter, to the lysosome in human embryonic kidney 293 cells."	3	bind|inhibit bind|inhibiting	FLCN	PAT1	30446510
 Suppression of either Rab11A or FLCN facilitated the localization of the overexpressed PAT1 to the lysosome and inhibited its targeting on the plasma membrane.	7	facilitate|inhibitd	FLCN	PAT1	30446510
" Instead, we found FLCN promoted the loading of PAT1 on Rab11A."	10	promoted	FLCN	PAT1	30446510
FLCN is a novel Rab11A-interacting protein that is involved in the Rab11A-mediated recycling transport.	1	Rab11A-interacting	FLCN	Rab11A	30446510
" Here we report that FLCN can bind through its C-terminal DENN-like domain to the recycling transport regulator, Rab11A."	6	bind	FLCN	Rab11A	30446510
			FLCN	Rab11A	30446510
			FLCN	Rab11A	30446510
" Instead, we found FLCN promoted the loading of PAT1 on Rab11A."	10	promoted	FLCN	Rab11A	30446510
			FLCN	Rab11A	30446510
 Suppression of either Rab11A or FLCN facilitated the localization of the overexpressed PAT1 to the lysosome and inhibited its targeting on the plasma membrane.	7	facilitate|inhibitd	PAT1	Rab11A	30446510
			PAT1	Rab11A	30446510
			MCT1	MCT2	30446621
			MCT1	MCT4	30446621
" The transport activity of MCT1, MCT2, and MCT4 can be facilitated by the extracellular carbonic anhydrase IV (CAIV) via a noncatalytic mechanism."	3	facilitated	MCT1	CAIV	30446621
			MCT1	CD147	30446621
			MCT1	GP70	30446621
			MCT2	MCT4	30446621
" The transport activity of MCT1, MCT2, and MCT4 can be facilitated by the extracellular carbonic anhydrase IV (CAIV) via a noncatalytic mechanism."	3	facilitated	MCT2	CAIV	30446621
			MCT2	CD147	30446621
			MCT2	GP70	30446621
" The transport activity of MCT1, MCT2, and MCT4 can be facilitated by the extracellular carbonic anhydrase IV (CAIV) via a noncatalytic mechanism."	3	facilitated	MCT4	CAIV	30446621
			MCT4	CD147	30446621
			MCT4	GP70	30446621
			CAIV	CD147	30446621
" In human CD147, binding of CAIV was mediated by the negatively charged Glu-73 and in rat CD147 by the positively charged Lys-73."	8	binding	CAIV	CD147	30446621
			CAIV	GP70	30446621
			CD147	GP70	30446621
			CD147	GP70	30446621
			SETDB1	DPPA2	30446626
			SETDB1	OTX2	30446626
			SETDB1	UTF1	30446626
			SETDB1	SMAD1	30446626
			DPPA2	OTX2	30446626
			DPPA2	UTF1	30446626
" Furthermore, DPPA2, OTX2 and UTF1 binding is increased in genes encoding BMP4 signaling-related proteins, including SMAD1."	6	bind|increase|relateing bind|increase|related signaling-bind|increase|related	DPPA2	SMAD1	30446626
			OTX2	UTF1	30446626
" Furthermore, DPPA2, OTX2 and UTF1 binding is increased in genes encoding BMP4 signaling-related proteins, including SMAD1."	6	bind|increase|relateing bind|increase|related signaling-bind|increase|related	OTX2	SMAD1	30446626
" Furthermore, DPPA2, OTX2 and UTF1 binding is increased in genes encoding BMP4 signaling-related proteins, including SMAD1."	6	bind|increase|relateing bind|increase|related signaling-bind|increase|related	UTF1	SMAD1	30446626
" Molecularly, the results revealed that knock down of TSG101 significantly decreased the cell cycle related regulatory factor p53 and p21."	5	decrease|related decrease|related	TSG101	p53	30450735
" Further investigation showed that TSG101 interacted with PEG10 and protected&#xa0;it&#xa0;from&#xa0;proteasomal&#xa0;degradation thereby regulating the expression of p53, p21 and MMPs."	9	interacted	TSG101	p53	30450735
" Molecularly, the results revealed that knock down of TSG101 significantly decreased the cell cycle related regulatory factor p53 and p21."	5	decrease|related decrease|related	TSG101	p21	30450735
" Further investigation showed that TSG101 interacted with PEG10 and protected&#xa0;it&#xa0;from&#xa0;proteasomal&#xa0;degradation thereby regulating the expression of p53, p21 and MMPs."	9	interacted	TSG101	p21	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitd decrease|inhibitor	TSG101	TIMP1	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitd decrease|inhibitor decrease|inhibitors decrease|inhibition	TSG101	MMP2	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitd decrease|inhibitor decrease|inhibitors decrease|inhibition	TSG101	MMP7	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitd decrease|inhibitor decrease|inhibitors decrease|inhibition	TSG101	MMP9	30450735
"TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10."	1	promotes	TSG101	PEG10	30450735
			TSG101	PEG10	30450735
" Further investigation showed that TSG101 interacted with PEG10 and protected&#xa0;it&#xa0;from&#xa0;proteasomal&#xa0;degradation thereby regulating the expression of p53, p21 and MMPs."	9	interacted	TSG101	PEG10	30450735
			TSG101	PEG10	30450735
" In conclusion, these results suggest that TSG101 is up-regulated in human HCC patients, which may accelerate the proliferation, migration and invasion of HCC cells through regulating PEG10."	11	up-regulated	TSG101	PEG10	30450735
			p53	p21	30450735
			p53	p21	30450735
			p53	TIMP1	30450735
			p53	MMP2	30450735
			p53	MMP7	30450735
			p53	MMP9	30450735
			p53	PEG10	30450735
			p21	TIMP1	30450735
			p21	MMP2	30450735
			p21	MMP7	30450735
			p21	MMP9	30450735
			p21	PEG10	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitors decrease|inhibition	TIMP1	MMP2	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitors decrease|inhibition	TIMP1	MMP7	30450735
" In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9."	6	decrease|inhibitors decrease|inhibition	TIMP1	MMP9	30450735
			TIMP1	PEG10	30450735
			MMP2	MMP7	30450735
			MMP2	MMP9	30450735
			MMP2	PEG10	30450735
			MMP7	MMP9	30450735
			MMP7	PEG10	30450735
			MMP9	PEG10	30450735
			ATF4	DEFA1	30452920
			ATF4	DEFA4	30452920
			ATF4	DEFA5	30452920
			ATF4	CAMP	30452920
			ATF4	LYZ1	30452920
" We found that expression of solute carrier family 1 member 5 (SLC1A5), a glutamine transporter, was directly regulated by ATF4 in cell lines."	17	regulated	ATF4	SLC1A5	30452920
" Knockdown of ATF4 in IEC-18 cells increased expression of inflammatory cytokines, whereas overexpression of SLC1A5 in the knockdown cells reduced cytokine expression."	19	increase|reduced	ATF4	SLC1A5	30452920
 Levels of SLC1A5 were decreased in inflamed intestinal mucosa of patients with CD and UC and correlated with levels of ATF4.	20	decrease|related cordecrease|related	ATF4	SLC1A5	30452920
			DEFA1	DEFA4	30452920
			DEFA1	DEFA5	30452920
			DEFA1	CAMP	30452920
			DEFA1	LYZ1	30452920
			DEFA1	SLC1A5	30452920
			DEFA4	DEFA5	30452920
			DEFA4	CAMP	30452920
			DEFA4	LYZ1	30452920
			DEFA4	SLC1A5	30452920
			DEFA5	CAMP	30452920
			DEFA5	LYZ1	30452920
			DEFA5	SLC1A5	30452920
			CAMP	LYZ1	30452920
			CAMP	SLC1A5	30452920
			LYZ1	SLC1A5	30452920